Pulmonary Surfactant-Associated Protein D
"Pulmonary Surfactant-Associated Protein D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens and enhances their opsinization and killing by phagocytic cells. Surfactant protein D contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.
| Descriptor ID |
D037663
|
| MeSH Number(s) |
D12.776.503.280.249.625 D12.776.823.249
|
| Concept/Terms |
Pulmonary Surfactant-Associated Protein D- Pulmonary Surfactant-Associated Protein D
- Pulmonary Surfactant Associated Protein D
- Lung Protein D
- Surfactant-Associated Glycoprotein D
- Surfactant Associated Glycoprotein D
- Surfactant Protein D
- SP-D
- Pulmonary Surfactant Protein D
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Surfactant-Associated Protein D".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Surfactant-Associated Protein D".
This graph shows the total number of publications written about "Pulmonary Surfactant-Associated Protein D" by people in this website by year, and whether "Pulmonary Surfactant-Associated Protein D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pulmonary Surfactant-Associated Protein D" by people in Profiles.
-
Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity. BMC Infect Dis. 2021 Aug 03; 21(1):737.
-
Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2. Biomolecules. 2021 07 28; 11(8).
-
The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study. J Med Virol. 2021 10; 93(10):6008-6015.
-
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019. J Infect Dis. 2021 07 02; 224(1):21-30.
-
A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples. Am J Respir Cell Mol Biol. 2021 07; 65(1):41-53.
-
Distinct temporal characteristics of circulating alveolar epithelial and endothelial injury markers in ARDS with COVID-19. Crit Care. 2021 05 17; 25(1):169.
-
Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Front Immunol. 2021; 12:641360.
-
Downregulation of type III interferons in patients with severe COVID-19. J Med Virol. 2021 07; 93(7):4559-4563.
-
Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: Down-modulation by H4 binding to C-reactive protein and Surfactant protein D. PLoS One. 2021; 16(2):e0247605.
-
Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19? Lung. 2020 10; 198(5):777-784.